Nicolas F Villarino

9PUBLICATIONS
9CO-AUTHORS
Carbon capture engineering (excl. sequestration)Cancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptidesToxicology (incl. clinical toxicology)Veterinary pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 17, 2026
Prevalence of the AIM exon 3 duplication variant, a putative biomarker associated with progression of kidney disease, in 1000 cats.

|Mar 09, 2026
Should Injectable Meloxicam Be Approved for Use in Cats?

Matthew K Wun, Michael H Court, Nicolas F Villarino

|Jan 19, 2026
Evaluation of Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2), Insulin-Like Growth Factor-Binding Protein-7 (IGFBP-7), and Kidney Injury Molecule-1 (KIM-1) as Biomarkers for the Detection of Meloxicam-Induced Kidney Injury in Cats.

Matthew K Wun, Julianne K Hwang, Nicolas F Villarino

|Dec 04, 2025
Pharmacokinetics and Safety of a Single Subcutaneous or Intramuscular Dose of Ketamine in Healthy Horses.

Ana Rangel, Debra C Sellon, Macarena G Sanz

|Aug 08, 2025
Response to the Letter to the Editor Regarding "Recommendations for a Complete Reporting of Statistical Methods in Veterinary Pharmacology".

Nicolas F Villarino

|Jun 06, 2025
Recommendations for a Complete Reporting of Statistical Methods in Veterinary Pharmacology.

Nicolas F Villarino

Pageof 2

Frequent Collaborators

2 joint publications

Liam E Broughton-Neiswanger

2 joint publications

Michael H Court

2 joint publications

Matthew K Wun

1 joint publications

Julianne K Hwang